FDA last week approved a first-of-its-kind late-stage breast cancer treatment that delivers a potent chemotherapy drug directly to cancer cells, leaving healthy cells relatively intact.
More than 1.5 million U.S. residents were diagnosed with invasive cancers in 2009—and a new CDC report indicates that new cases were most common in the Northeast.
Print All Daily Briefing Article from
02/26/2013
Share:
Have a Question?
x
Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.
